BGC-001

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBGC-001
Drug Alias Nameincrementally modified drug (Boryung)BGC-001
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStomach UlcerGastritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBoryung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsStomach UlcerGastritis

Other Information

ATC CodeN/A
Related LinksN/A